Navigation Links
Karyopharm Therapeutics Inc. and Katholieke Universiteit Leuven Sign Exclusive Collaboration for the Discovery of Novel CRM1/Exportin 1 Inhibitors
Date:10/11/2011

NATICK, Mass., Oct. 11, 2011 /PRNewswire/ -- Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modulators, has initiated an exclusive collaboration in the area of Selective Inhibitors of Nuclear Export (SINE) modulators of the CRM1 protein with the Rega Institute for Medical Research, a part of the Katholieke University of Leuven (K.U.Leuven), Belgium. The nuclear transport machinery plays an integral role in the regulation of many molecules involved in a broad spectrum of human and animal disease. Karyopharm will work with scientists lead by Dr. Dirk Daelemans of the Laboratory of Virology and Chemotherapy at the Rega Institute on the discovery and development of novel SINE CRM1 inhibitors. Together, the groups will expand the portfolio of Karyopharm's SINE CRM1 antagonists for the treatment of cancer, autoimmune diseases and viral disorders.

Dr. Dirk Daelemans and his colleagues at the Rega Institute have done pioneering work in the area of nuclear export modulation, particularly in their roles in viral replication. Dr. Daelemans said, "We are very pleased to be working with the team at Karyopharm, as they are in a leading position to move our combined portfolio of compounds into development for the treatment of human diseases."  Sharon Shacham, PhD, MBA, Karyopharm's CSO and Head of R&D, commented, "This collaboration with the Rega Institute, one of the world's leaders in elucidation of mechanism of action of biologically active compounds, further strengthens our research and development platform dedicated to bringing the first nuclear export inhibitors to the clinic for cancer and other disorders." It is anticipated that the collaboration will discover novel CRM1 inhibitors, beyond those already patented by Karyopharm.

About Karyopharm

Karyopharm is a preclinical-stage biopharmaceutical company leading the development of small molecule modulators of nuclear transport.  The Company was
'/>"/>

SOURCE Karyopharm Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
2. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
3. Echo Therapeutics Hires Product Development Management Executive
4. Prime Therapeutics Demonstrates Willingness to Show Actual Pharmacy Costs
5. Echo Therapeutics Announces Positive Results of Clinical Trial of Its Symphony® Continuous Glucose Monitoring System
6. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
7. Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value
8. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
9. Orexigen® Therapeutics Presents Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
10. Acute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
11. Independent Radiology Assessment Panel Results Confirm Statistical Significance of Response and Progression Endpoints of Cell Therapeutics Pixantrone PIX301 Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Conn. , Aug. 21, 2014  Aptuit ... West Lafayette, Indiana , has enhanced ... and characterization of small and large molecules, including ... of the Bruker maXisPlus Q-TOF mass spectrometer. ... Goldman , CEO, Aptuit, said, "The expanded large ...
(Date:8/21/2014)... , Aug. 21, 2014   Memorial Hermann Health ... Cancer Center today announced a new partnership to provide ... of community breast care centers in the greater ... MD Anderson will become the exclusive provider of professional breast ... centers, located in Memorial City, The Woodlands ...
(Date:8/21/2014)... , Aug. 21, 2014  Vermillion, Inc. (NASDAQ: ... gynecologic cancers and women,s health, has appointed Holly ... Managed Markets. Ms. Bauzon has a proven ... payer coverage for laboratory services companies. She has more ... PerkinElmer, Inc., where she held the position of Director, ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... 7, 2012  Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, ... dermatology biopharmaceutical company, today announced that its ... for on-demand viewing. LINK:  ... now" button Provectus Pharmaceuticals, Inc,s ...
... May 7, 2012 A new analysis concludes that rituximab, ... treatment responses lasting at least five years in approximately one ... of bleeding due to chronic immune thrombocytopenic purpura (ITP). In ... Blood , the Journal of the American Society ...
Cached Medicine Technology:Provectus Pharmaceuticals, Inc.'s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 2Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 3
(Date:8/21/2014)... The “Proteomics Market by Technology ... Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents ... and studies the major market drivers, restraints, and ... Rest of the World (RoW) , Browse 138 ... pages and in-depth TOC on “Proteomics Market by ...
(Date:8/21/2014)... Salt Lake City, Utah (PRWEB) August 21, 2014 ... http://www.avechealth.com ) is pleased to announce the addition ... With over 30 years of healthcare management experience, ... His experience includes multiple executive management positions ... , Most recently Kerry served as President of ...
(Date:8/21/2014)... DoudouneCanadienneGoosePasCher.fr, one of the most popular suppliers ... its new selection of Trillium Parkas for 2014. Moreover, ... these fashionable and comfortable items are available at discounted ... last until September 01. , The CEO says ... Canada Goose Trillium Parkas for new and old ...
(Date:8/21/2014)... The costs paid by consumers each year ... to insurer data. The Quotes Pros company is now helping ... its tools at http://quotespros.com . , The automatic ... with providers offering multiple coverage packages for dental related care ... public are now easier to compare using the all-in-one digital ...
(Date:8/21/2014)... 21, 2014 Pack Expo is ... and Processing Technologies. They deliver the industry’s best ... a whole new world of advancement and opportunity. ... education, and the latest technology and innovations in ... This year at Pack Expo International, 50,000 attendees ...
Breaking Medicine News(10 mins):Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 5Health News:Kerry Gillespie Appointed as Chief Executive Officer of AVEC Health Solutions 2Health News:Fashionable And Comfortable Canada Goose Trillium Parkas For Sale At DoudouneCanadienneGoosePasCher.fr 2Health News:Dental Insurance Now Quoted for Families Online at Insurer Portal 2Health News:Absolute I&D Provides Discounted Labor for Pack Expo Chicago 2
... a condition of the skin that affects more than 80 ... While stress has often been cited // as a source ... ,Twenty-two university students participated in this study. Each participant had ... study. Exam sessions are common sources of stress for students. ...
... report more than half a million women in developing countries ... Safe Motherhood and Newborn Health //are intensifying support to countries ... die while giving birth to her child. ,The ... skilled birth attendants who can help a woman give birth ...
... integrate cardiovascular activity into their lives, such as walking, would ... the study researchers surveyed nearly 18,800 women, ages 70 to ... The data show women who walked for at least 1.5 ... than those who walked less than 40 minutes per week. ...
... reduces the risk of recurrence in women with stage I ... ovary). ,About one quarter of all ovarian cancers are ... 85 percent. Most doctors may prefer not to offer chemotherapy ... treated by surgery alone , thus doctors say that giving ...
... room may be the healthiest environment for your child at ... // may put children at risk for leukemia. Researchers ... the circadian rhythm and suppress the production of melatonin. ... to protect DNA from oxidative damage. Once damaged, DNA may ...
... best friend might be able to detect bladder cancer . ... from malignant tumors in urine samples. ,Six dogs ... to discriminate between urine from patients with bladder cancer and ... samples of urine from six control group participants and one ...
Cached Medicine News:Health News:WHO acts to reduce the maternal death toll 2
Single-Piece PMMA Intraocular Lenses....
Single Piece PMMA Lens (Refractive and Bifocal). Anterior chamber Lens....
Hydrophilic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens....
STABIBAG Hydrophilic Acrylic Lens....
Medicine Products: